During the inaugural event of expanded Process and Analytical Development Laboratories at Lonza Netherlands, leaders and innovators from the industry look the stage for a panel discussion around process development and commercial readiness for cell & gene therapy manufacturing.
Anthony Davies, Chair, CEO, Dark Horse Consulting
Felix Hermann, Vice President of CMC, Cimeio Therapeutics
Chaminda Salgado, Vice President of CMC, T-Cypher Bio
Erik Rutjens, Chief Technical Officer, CanCell Therapeutics
Behnam Ahmadian Baghbaderani, Global Head of CGT Process Development, Lonza